Skip to main content

Human Papilloma Virus: Vaccinations

Volume 464: debated on Tuesday 16 October 2007

To ask the Secretary of State for Health (1) whether his Department is taking steps to ensure that young women who left school in summer 2007 before the human papilloma virus vaccination programme was introduced have access to this vaccination on the NHS; (157998)

(2) what decision has been made by his Department regarding a catch-up campaign for the human papilloma virus vaccine for females aged between 12 to 26 years.

The Department has agreed, in principle, to accept Joint Committee on Vaccination and Immunisation (JCVI) advice that human papilloma virus vaccines should be introduced routinely for girls aged around 12 to 13 years, subject to independent peer review of the cost-benefit analysis.

A detailed analysis is being carried out by the JCVI regarding the cost-benefit analysis, and this work is being externally peer reviewed to ensure its robustness. The Department will consider the issue when the advice from JCVI is available.